Kezar Life Sciences, Inc.
KZRDelisted May 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645666
Kezar Life Sciences, Inc. was delisted on May 11, 2026; its insiders filed their last Form 4 on May 11, 2026; 43 institutions reported holding it in 13F filings for Q1 2026, worth $32.8M in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Kezar Life Sciences, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 107
- +30 vs. Q3 2021
- Shares held
- 40.4M
- +12.3M (+43.9%) vs. Q3 2021
- Total value
- $674.1M
- +$431.4M (+177.7%) vs. Q3 2021
- New holders
- 39
- 34 more added
- Sold out
- 9
- 22 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KZR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 43 | $32.8M |
| Q4 2025 | 43 | $28.1M |
| Q3 2025 | 39 | $16.5M |
| Q2 2025 | 40 | $20.5M |
| Q1 2025 | 41 | $21.1M |
| Q4 2024 | 43 | $28.2M |
| Q3 2024 | 60 | $31.6M |
| Q2 2024 | 81 | $23.6M |
| Q1 2024 | 85 | $40.3M |
| Q4 2023 | 81 | $46.8M |
| Q3 2023 | 82 | $66.0M |
| Q2 2023 | 104 | $139.4M |
| Q1 2023 | 137 | $188.1M |
| Q4 2022 | 123 | $404.2M |
| Q3 2022 | 132 | $495.5M |
| Q2 2022 | 127 | $454.0M |
| Q1 2022 | 123 | $734.1M |
| Q4 2021 | 107 | $674.1M |
| Q3 2021 | 77 | $242.7M |
| Q2 2021 | 75 | $150.1M |
| Q1 2021 | 83 | $158.0M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Kezar Life Sciences, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,891,415 | $31.6M | 0.00% | −25,434−1.3% | Reduced |
| Adage Capital Partners GP, L.L.C. | 2,056,672 | $34.4M | 0.06% | +2,056,672 | New |
| Point72 Asset Management, L.P. | 2,105,490 | $35.2M | 0.16% | +2,105,490 | New |
| Franklin Resources Inc | 2,486,186 | $41.6M | 0.01% | +207,837+9.1% | Added |
| BlackRock Inc. | 2,687,024 | $44.9M | 0.00% | +55,208+2.1% | Added |
| Avidity Partners Management LP | 3,228,200 | $54.0M | 1.14% | +2,968,200+1,141.6% | Added |
| Bellevue Group AG | 4,918,148 | $82.2M | 0.85% | +385,000+8.5% | Added |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −1,150,000−100.0% | Sold out |
| AJU IB Investment Co., Ltd. | 0 | $0 | 0.00% | −128,916−100.0% | Sold out |
| Grantham, Mayo, Van Otterloo & Co. LLC | 0 | $0 | 0.00% | −70,319−100.0% | Sold out |
| Martingale Asset Management L P | 0 | $0 | 0.00% | −26,119−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −12,566−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −6,009−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −1,100−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −604−100.0% | Sold out |
| Meridian Wealth Partners, LLC | 0 | $0 | 0.00% | −233−100.0% | Sold out |